Compare EDTK & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EDTK | ALUR |
|---|---|---|
| Founded | 2013 | 2009 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.7M | 15.4M |
| IPO Year | 2020 | N/A |
| Metric | EDTK | ALUR |
|---|---|---|
| Price | $1.00 | $1.68 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.25 |
| AVG Volume (30 Days) | 2.7K | ★ 506.0K |
| Earning Date | 01-14-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $893,690.00 | ★ $17,208,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.02 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.80 | $1.02 |
| 52 Week High | $1.20 | $16.81 |
| Indicator | EDTK | ALUR |
|---|---|---|
| Relative Strength Index (RSI) | 45.71 | 54.37 |
| Support Level | $0.97 | $1.37 |
| Resistance Level | $1.06 | $1.79 |
| Average True Range (ATR) | 0.05 | 0.18 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 42.28 | 88.31 |
Skillful Craftsman Education Technology Ltd provides online education and technology services in China. The services comprises of two aspects - Online vocational training and Virtual simulation experimental training. It covers a wide range of subjects, including mechanics, electronics, auto repair and construction. Majority of its revenues are generated from the People's Republic of China.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.